SPOTLIGHT -
Most mild-to-moderate myopia could be treated with conventional therapy using excimer laser system
Aldeyra Therapeutics receives complete response letter from FDA for reproxalap NDA
Week in Review - November 12, 2023
Iridex successfully appeals for revision of recent Medicare LCDs to provide broader coverage of cyclophotocoagulation
Diabetic Macular Edema – Considering Pathogenesis in Treatment Selection
In Israel, business continues amid conflict
Vision Council release results of their Provider InSights research study for Q3